Skip to main content

Table 3 Associations between HDL genetic risk scores and HDL, LDL, triglycerides, and coronary artery calcified plaque (CAC)

From: Impact of HDL genetic risk scores on coronary artery calcified plaque and mortality in individuals with type 2 diabetes from the Diabetes Heart Study

 

Model 1

Model 2

Model 3

 

β Estimate (CI)

p-value

β Estimate (CI)

p-value

β Estimate (CI)

p-value

HDL

      

Risk score 1a

0.027 (-0.001- 0.055)

0.057

0.030 (0.005- 0.056)

0.022

0.033 (0.007- 0.058)

0.013

Risk score 1b

0.033 (0.003- 0.063)

0.031

0.034 (0.006- 0.061)

0.018

0.035 (0.008- 0.063)

0.012

Risk score 2a

0.046 (0.016- 0.076)

0.003

0.051 (0.023- 0.079)

3.85 × 10-4

0.052 (0.024- 0.080)

3.06 × 10-4

Risk score 2b

0.061 (0.034- 0.089)

1.42 × 10-5

0.062 (0.036- 0.088)

2.60 × 10-6

0.063 (0.037- 0.088)

1.44 × 10-6

Combined unweighted

0.035 (0.015- 0.055)

0.001

0.039 (0.021- 0.058)

3.63 × 10-5

0.040 (0.021- 0.058)

2.34 × 10-5

Combined weighted

0.043 (0.025- 0.061)

4.65 × 10-6

0.044 (0.027- 0.061)

4.90 × 10-7

0.044 (0.027- 0.061)

2.75 × 10-7

LDL

      

Risk score 1a

0.317 (-0.678- 1.311)

0.532

0.260 (-0.74- 1.260)

0.611

0.245 (-0.759- 1.248)

0.633

Risk score 1b

0.243 (-0.782- 1.268)

0.642

0.177 (-0.854- 1.207)

0.737

0.140 (-0.887- 1.167)

0.789

Risk score 2a

−0.823 (-1.978- 0.332)

0.163

−0.838 (-1.987- 0.312)

0.153

−0.805 (-1.955- 0.346)

0.170

Risk score 2b

−0.507 (-1.614- 0.600)

0.369

−0.604 (-1.713- 0.506)

0.286

−0.585 (-1.698- 0.529)

0.303

Combined unweighted

−0.243 (-1.018- 0.533)

0.539

−0.261 (-1.033- 0.512)

0.509

−0.266 (-1.038- 0.507)

0.501

Combined weighted

−0.260 (-0.988- 0.468)

0.484

−0.325 (-1.054- 0.404)

0.383

−0.327 (-1.060- 0.406)

0.381

Triglycerides

      

Risk score 1a

−0.002 (-0.019- 0.015)

0.853

−0.005 (-0.021- 0.012)

0.591

−0.006 (-0.022- 0.010)

0.469

Risk score 1b

−0.005 (-0.022- 0.013)

0.595

−0.007 (-0.024- 0.010)

0.402

−0.008 (-0.024- 0.009)

0.374

Risk score 2a

−0.013 (-0.034- 0.008)

0.220

−0.016 (-0.036- 0.004)

0.123

−0.015 (-0.036- 0.005)

0.133

Risk score 2b

−0.009 (-0.028- 0.010)

0.370

−0.013 (-0.031- 0.005)

0.162

−0.013 (-0.031- 0.005)

0.163

Combined unweighted

−0.010 (-0.023- 0.004)

0.157

−0.012 (-0.025- 0.001)

0.076

−0.012 (-0.025- 0.001)

0.072

Combined weighted

−0.007 (-0.020- 0.005)

0.246

−0.010 (-0.022- 0.002)

0.092

−0.010 (-0.022- 0.002)

0.096

Coronary Artery Calcified Plaque (CAC)

      

Risk score 1a

−0.079 (-0.154- -0.003)

0.042

−0.065 (-0.128- -0.001)

0.046

−0.068 (-0.128- -0.008)

0.027

Risk score 1b

−0.067 (-0.146- 0.012)

0.097

−0.053 (-0.119- 0.014)

0.119

−0.059 (-0.123- 0.004)

0.065

Risk score 2a

−0.072 (-0.154- 0.011)

0.089

−0.063 (-0.134- 0.009)

0.085

−0.082 (-0.149- -0.014)

0.017

Risk score 2b

−0.117 (-0.197- -0.036)

0.005

−0.088 (-0.156- -0.020)

0.011

−0.101 (-0.163- -0.038)

0.002

Combined unweighted

−0.083 (-0.140- -0.026)

0.004

−0.077 (-0.123- -0.031)

0.001

−0.080 (-0.124- -0.037)

3.18 × 10-4

Combined weighted

−0.087 (-0.141- -0.033)

0.002

−0.069 (-0.114- -0.024)

0.002

−0.075 (-0.117- -0.034)

3.85 × 10-4

  1. Analysis was performed using marginal models with generalized estimating equations. Model 1 is unadjusted; Model 2 is adjusted for age, sex, and body mass index (BMI); Model 3 is adjusted for age, sex, BMI, smoking, hypertension, and prior cardiovascular disease. Associations are reported as the β estimate and its 95% confidence interval (CI).